SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:hh-54343"
 

Sökning: onr:"swepub:oai:DiVA.org:hh-54343" > Drug repositioning ...

Drug repositioning by multi-aspect heterogeneous graph contrastive learning and positive-fusion negative sampling strategy

Liu, Junkai (författare)
Suzhou University Of Science And Technology, Suzhou, China; University Of Electronic Science And Technology Of China, Chengdu, China
Hu, Fuyuan (författare)
Suzhou University Of Science And Technology, Suzhou, China
Zou, Quan (författare)
University Of Electronic Science And Technology Of China, Chengdu, China
visa fler...
Tiwari, Prayag, 1991- (författare)
Högskolan i Halmstad,Akademin för informationsteknologi
Wu, Hongjie (författare)
Suzhou University Of Science And Technology, Suzhou, China
Ding, Yijie (författare)
University Of Electronic Science And Technology Of China, Chengdu, China
visa färre...
 (creator_code:org_t)
Amsterdam : Elsevier, 2024
2024
Engelska.
Ingår i: Information Fusion. - Amsterdam : Elsevier. - 1566-2535 .- 1872-6305. ; 112
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Drug repositioning (DR) is a promising approach for identifying novel indications of existing drugs. Computational methods for drug repositioning have been recognised as effective ways to discover the associations between drugs and diseases. However, most computational DR methods ignore the significance of heterogeneous graph augmentation when conducting contrastive learning, which plays a critical role in improving the generalisation and robustness. The high-order similarity information from multiple data sources is still under-explored. Furthermore, only a limited number of computational DR methods can effectively screen for the most informative negative samples for model training. To address these limitations, we propose a novel DR method called DRMAHGC that employs multi-aspect graph contrastive learning to predict drug-disease associations (DDAs). First, high-order features were generated from the similarity network using a graph-masked autoencoder. Then, heterogeneous graph contrastive learning with structure- and metapath-level augmentation was employed to enhance semantic comprehension and learn expressive representations. Subsequently, the positive-fusion negative sampling strategy was exploited to synthesise informative negative sample embeddings to train the classifier for predicting novel DDAs. Extensive results on three benchmark datasets indicate that DRMAHGC significantly and consistently outperformed the state-of-the-art methods in the DR task. Moreover, the case study of two common diseases further demonstrates its effectiveness and provides novel insights into DRMAHGC in identifying novel DDAs. © 2024 The Author(s)

Ämnesord

NATURVETENSKAP  -- Data- och informationsvetenskap -- Datavetenskap (hsv//swe)
NATURAL SCIENCES  -- Computer and Information Sciences -- Computer Sciences (hsv//eng)

Nyckelord

Drug repositioning
Drug-disease associations
Graph contrastive learning
Heterogeneous graph augmentation
Negative sampling
Positive-fusion

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy